Full name
"ALLERGOPHARMA-NEXTER" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
73.11.Z - Advertising agency activities
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,7 | 0,5 | -1,3 | -365,5 |
EBITDA | 1,7 | 0,5 | -1,3 | -363,9 |
Short time liabilities | 0 | 0,1 | 0 | -53,8 |
Equity capital | 3,6 | 4 | 2,6 | -33,6 |
Operating profit (EBIT) | 1,7 | 0,5 | -1,4 | -382,9 |
Assets | 3,6 | 4,1 | 2,7 | -34,1 |
Net profit (loss) | 1,4 | 0,4 | -1,3 | -435,9 |
Cash | 1,3 | 1,8 | 1,5 | -18,4 |
Net income from sale | 4,7 | 3,6 | 0,2 | -93,6 |
Liabilities and provisions for liabilities | 0 | 0,1 | 0 | -53,8 |
Working assets | 2,9 | 3,4 | 2,1 | -39,6 |
Depreciation | 0 | 0 | 0 | -32 |
% | % | % | p.p. | |
Profitability of capital | 39,7 | 10 | -50,6 | -60,6 |
Equity capital to total assets | 99,2 | 97,5 | 98,2 | 0,7 |
Gross profit margin | 35,9 | 14 | -580,1 | -594,1 |
EBITDA Margin | 36,2 | 14,2 | -587,3 | -601,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 | 10 | 75 | 65 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane